Clinical Trials

Alliance A031501

Randomized phase III trial studying how well Pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes.

Objective

This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes. Monoclonal antibodies recognizing and blocking checkpoint molecules can enhance the patient's immune response and therefore help fight cancer. Pembrolizumab is one of the monoclonal antibodies that block the PD-1 axis and can interfere with the ability of tumor cells to grow.

NCT# 03244384

Clinical Trial Categories

  • Bladder Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at (603) 224-2556

Location

  • Payson Center for Cancer Care
    Concord Hospital
    250 Pleasant Street
    Concord, NH 03301
    Main: (603) 230-6000